Effect of Antidiabetic Drugs on Blood Coagulation in Diabetic Patients

Background-Diabetes mellitus (DM) is a common endocrine disorder. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are basic haematological indices to screen the coagulation status. Due to persistent hyperglycemia, glycation of proteins involved in clotting mechanism takes place which reduces their availability, thus affecting the clotting capacity. Method- An analytical observational study was conducted on 180 subjects by measuring their PT and aPTT, to observe the effect of antidiabetic drugs on blood coagulation and to compare these indices between treated and untreated diabetics. Results- A significant elevation of PT and aPTT in untreated diabetics when compared to controls was seen (PT (p<0.001); aPTT (p<0.05)). The effect of antidiabetic drugs showed normal mean values of PT and aPTT in treated group (p>0.05). Conclusion- the study revealed that significant elevation of PT and aPTT in untreated DM than non diabetic controls may be interpreted as tendency to bleed while effect of anti diabetic drugs shows normal mean values of PT and aPTT in treated group. This suggests that antidiabetic drugs either in combination or monotherapy may normalize PT and aPTT by reducing glycation of hemoglobin. Therefore, routine examinations of PT and aPTT are important to assess coagulation impairment in diabetes mellitus so as to prevent cardiovascular disease.

• Publication year

  2022

• Venue

  Biomedical & Pharmacology Journal

• Publication date

  2022-12-20

• Fields of study

  Not labeled

• Identifiers
  DOI 10.13005/bpj/2577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Certain Oral Anti Diabetic Drugs on Coagulation Cascade in Diabetes Mellitus

  2017cited by this paper
• Coagulation Impairment in Type 2 Diabetes Mellitus

  2015cited by this paper
• Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus

  2013cited by this paper
• Influence of antioxidant vitamins supplementation on blood glucose levels and body wastages of alloxan-induced diabetic rats.

  2012cited by this paper
• Evaluation of Prothrombin Time and Activated Partial Thromboplastin in Patients with Diabetes Mellitus

  2012cited by this paper
• Anticoagulant effects of an antidiabetic drug on monocytes in vitro.

  2011cited by this paper
• Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values

  2011cited by this paper
• ANTIOXIDANT MICRONUTRIENT POTENTIALS IN STRENGTHENING THE ANTIOXIDANT DEFENSE IN ALLOXAN-INDUCED DIABETIC RATS

  2010cited by this paper
• Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

  2010cited by this paper
• Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

  2010cited by this paper
• Hyperglycemia: a prothrombotic factor?

  2010cited by this paper
• Epidemiological association between fasting plasma glucose and shortened APTT.

  2009cited by this paper
• Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes

  2006cited by this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cited by this paper
• Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes.

  2004cited by this paper
• Diabetes, oxidative stress, and antioxidants: A review

  2003cited by this paper
• Cardiovascular Safety of Oral Antidiabetic Agents: The Insulin Secretagogues

  2002cited by this paper
• Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.

  1991cited by this paper

• No citing papers are available for this paper.